https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Experimental studies have shown that celecoxib is related to the downregulation of Tregs and an increase in the therapeutic efficacy of PD-1 inhibitors; however, such effect has not been shown in human cancers. Our report confirmed the synergistic effect of celecoxib with a PD-1 inhibitor. A 57-year-old male with advanced pulmonary adenocarcinoma was treated with nivolumab monotherapy as 5 line sequential treatment. Although the patient experienced tumor remission, regrowth of the primary tumor was observed and he comp
Like
Comment
Share
